Steroid-refractory Acute Graft-versus-host Disease research hub

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

This study is looking at a new treatment called MC0518 for children and young people with a serious condition called 'steroid-refractory acute graft-versus-host disease' (SR-aGvHD). It compares MC0518 to standard treatments to see if it works better.